✦ LIBER ✦

Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

✍ Scribed by Elisabetta Munzone, Giuseppe Curigliano, Andrea Rocca…

Book ID: 120700063
Publisher: BioMed Central
Year: 2005
Tongue: English
Weight: 92 KB
Volume: 8
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr1366

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Correction: Reverting estrogen-receptor-

Correction: Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

✍ Elisabetta Munzone, Giuseppe Curigliano, Andrea Rocca… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 25 KB

Trastuzumab (T) plus oral vinorelbine (O

Trastuzumab (T) plus oral vinorelbine (OV) in patients with advanced breast cancer (ABC) overexpressing Her2/neu

✍ C. Catania; Adamoli; L. Franceschelli; C. Marenghi; G. Ascione; G. Sanna; E. Ver 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Hormone-receptor expression and activity

Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

✍ Filippo Montemurro; Valentina Rossi; Maria Cossu Rocca; Rossella Martinello; Ele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Herceptin (trastuzumab) in patients who

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study

✍ G Westman 📂 Article 📅 2000 🏛 BioMed Central 🌐 English ⚖ 298 KB

HER2 and ESR1 mRNA expression levels and

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

✍ Carsten Denkert, Jens Huober, Sibylle Loibl, Judith Prinzler… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 458 KB

Analysis of the Pathologic Response to P

Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status

✍ Luis A. Fernández-Morales; Miquel A. Seguí; Xavier Andreu; Elsa Dalmau; Amparo S 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 105 KB